Compare Stocks: HELP vs. ACHV vs. ANL vs. ACRS
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
HELPACHVANLACRS
Market Snapshot
Current market context for the selected companies.
HELP
$11.77
Market Cap
873.07M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
ACHV
$8.29
Market Cap
$872.61M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
ANL
$14.66
Market Cap
$892.23M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
ACRS
$5.95
Market Cap
$909.69M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-09-03
Performance
Absolute returns and relative performance versus SPY.
| Metric | HELP | ACHV | ANL | ACRS |
|---|---|---|---|---|
| 1 Month | +11.8% | +24.5% | +12.2% | -6.5% |
| 1 Month vs SPY | +11.4% | +24.2% | +11.8% | -6.9% |
| 3 Months | +165.7% | +56.8% | +33.3% | +26.2% |
| 3 Months vs SPY | +163.6% | +54.7% | +31.3% | +24.2% |
| 6 Months | +108.7% | +88.5% | +58.7% | +90.5% |
| 6 Months vs SPY | +95.3% | +75.1% | +45.3% | +77.1% |
| 1 Year | +95.8% | +190.0% | +723.9% | +188.6% |
| 1 Year vs SPY | +75.8% | +170.0% | +703.8% | +168.6% |
| 2 Years | +21.0% | +87.2% | +433.3% | +408.1% |
| 2 Years vs SPY | -17.4% | +48.8% | +394.9% | +369.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.